UFC Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- UFC Biotechnology's estimated annual revenue is currently $1.6M per year.
- UFC Biotechnology's estimated revenue per employee is $155,000
Employee Data
- UFC Biotechnology has 10 Employees.
- UFC Biotechnology grew their employee count by -9% last year.
UFC Biotechnology's People
Name | Title | Email/Phone |
---|---|---|
1 | IT / Supply Chain Manager | Reveal Email/Phone |
UFC Biotechnology Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is UFC Biotechnology?
UFC Biotechnology is focused on providing products for Life Sciences here and abroad. UFC Biotechnology is focused on synthesizing high value molecules used in Life Sciences. It has the know-how on good portfolio of high value molecules used in Life Sciences. It aims to establish a synthesis laboratory at University at Buffalo campus to provide products for the Life Sciences marketplace. It will offer a number of high value molecules. UFC Biotechnology is also open to collaboration with local Life Sciences companies for custom synthesis. UFC Biotechnology formed a joint venture in the Middle East. This JV Company will provide a continually evolving portfolio of products designed to meet every day R&D needs for the growing area of molecular biology and Life Sciences in the region.
keywords:N/AN/A
Total Funding
10
Number of Employees
$1.6M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 10 | -17% | N/A |
#2 | $1.4M | 10 | -58% | N/A |
#3 | $1M | 11 | 10% | N/A |
#4 | $1M | 11 | 0% | N/A |
#5 | $1M | 12 | 9% | N/A |